KR20250073200A - 영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자 - Google Patents

영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자 Download PDF

Info

Publication number
KR20250073200A
KR20250073200A KR1020257012384A KR20257012384A KR20250073200A KR 20250073200 A KR20250073200 A KR 20250073200A KR 1020257012384 A KR1020257012384 A KR 1020257012384A KR 20257012384 A KR20257012384 A KR 20257012384A KR 20250073200 A KR20250073200 A KR 20250073200A
Authority
KR
South Korea
Prior art keywords
dota
glu
sifa
cck
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257012384A
Other languages
English (en)
Korean (ko)
Inventor
토마스 귄터
나딘 홀츠라이트너
한스 위르겐 베스터
콘스탄틴 라파
Original Assignee
테크니쉐 유니베르시테트 뮌헨
유니베르씨타트 아우크스부르크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테크니쉐 유니베르시테트 뮌헨, 유니베르씨타트 아우크스부르크 filed Critical 테크니쉐 유니베르시테트 뮌헨
Publication of KR20250073200A publication Critical patent/KR20250073200A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
KR1020257012384A 2022-09-20 2023-05-19 영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자 Pending KR20250073200A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22196630 2022-09-20
EP22196630.2 2022-09-20
PCT/EP2023/063469 WO2024061483A1 (en) 2022-09-20 2023-05-19 Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy

Publications (1)

Publication Number Publication Date
KR20250073200A true KR20250073200A (ko) 2025-05-27

Family

ID=83994946

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257012384A Pending KR20250073200A (ko) 2022-09-20 2023-05-19 영상화 및 표적화된 방사선요법을 위한 신규한 미니가스트린-유래된 콜레시스토키닌 2 수용체 결합 분자

Country Status (9)

Country Link
EP (2) EP4590347A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025532619A (cg-RX-API-DMAC7.html)
KR (1) KR20250073200A (cg-RX-API-DMAC7.html)
CN (1) CN119907695A (cg-RX-API-DMAC7.html)
AU (1) AU2023345654A1 (cg-RX-API-DMAC7.html)
CA (1) CA3264385A1 (cg-RX-API-DMAC7.html)
IL (1) IL319379A (cg-RX-API-DMAC7.html)
MX (1) MX2025003151A (cg-RX-API-DMAC7.html)
WO (1) WO2024061483A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12642876B1 (en) 2025-10-30 2026-06-02 Perspective Therapeutics, Inc. Cholecystokinin-2 receptor targeted compounds and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3412303A1 (en) * 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy
KR20240027896A (ko) * 2017-07-28 2024-03-04 테크니쉐 우니베르지테트 뮌헨 이중 모드 방사성 트레이서 및 치료법
EP4023250A1 (en) * 2021-01-04 2022-07-06 Technische Universität München Dual mode radiotracer and -therapeutics

Also Published As

Publication number Publication date
CA3264385A1 (en) 2024-03-28
CN119907695A (zh) 2025-04-29
JP2025532619A (ja) 2025-10-01
AU2023345654A1 (en) 2025-02-27
WO2024061483A1 (en) 2024-03-28
MX2025003151A (es) 2025-04-02
EP4590347A1 (en) 2025-07-30
IL319379A (en) 2025-05-01
EP4631959A3 (en) 2025-12-17
EP4631959A2 (en) 2025-10-15

Similar Documents

Publication Publication Date Title
JP7572080B2 (ja) 画像化および内部放射線療法のためのpsmaリガンド
CN111132700B (zh) 双模放射性示踪剂与治疗剂
JP2026031934A (ja) 安定した濃縮放射性医薬組成物
JP2024123022A (ja) ガストリン放出ペプチド受容体(grpr)のインビボイメージングおよびgrpr関連障害の治療のための放射性標識ボンベシン由来化合物
JP7838149B2 (ja) 癌のイメージングおよび治療のための修飾されたgrprアンタゴニストペプチド
AU2022219294A9 (en) Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof
EP4631959A2 (en) Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy
US20250313579A1 (en) Ligand compounds comprising a chelating group as a bridging group
JP2024517971A (ja) 放射性医薬品のソマトスタチン受容体リガンドおよびその前駆体
JP2025525111A (ja) 放射性医薬品のためのケイ素系フッ化物アクセプター基

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000